INS and type 2 diabetes mellitus: Deterioration of β-cell function over time is a primary reason that glycaemic control becomes increasingly challenging with the progression of type 2 diabetes 24 and some GLP-1 RAs also show promise in preserving and improving markers of β-cell function as evidenced by restoration of first-phase insulin secretion and enhancement of insulin synthesis and processing 19,20,25–27.